Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-25-016099
Filing Date
2025-02-21
Accepted
2025-02-21 16:10:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 27042
2 JOINT FILING AGREEMENT ea023120001ex99-1_zhengye.htm EX-99.1 8102
  Complete submission text file 0001213900-25-016099.txt   36813
Mailing Address NO.1 LIANMENG STREET, JILIN ECONOMIC & TECHNICAL DEVELOPMENT ZONE JILIN F4 132101
Business Address NO.1 LIANMENG STREET, JILIN ECONOMIC & TECHNICAL DEVELOPMENT ZONE JILIN F4 132101 86-13844801919
Zhengye Biotechnology Holding Ltd (Subject) CIK: 0001975641 (see all company filings)

EIN.: 000000000 | State of Incorp.: F4
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94896 | Film No.: 25651943
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address NO.1 LIANMENG ROAD JILIN F4 132101
Business Address NO.1 LIANMENG ROAD JILIN F4 132101 86-0432-63047008
SECURINGIUM HOLDING Ltd (Filed by) CIK: 0002057331 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G